アレルギー診断の市場規模、シェア、動向分析レポート：製品・サービス別、アレルゲン別、検査タイプ別、最終用途別、地域別、セグメント予測、2025～2030年

アレルギー診断市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界のアレルギー診断市場規模は、2025～2030年にかけて10.39%のCAGRを記録し、2030年までに116億3,000万米ドルに達する見込みです。

アレルギーは米国でも世界でも公衆衛生上の重大な問題であり続け、子供、成人の両方に影響を及ぼしています。CDCの2023年国民健康調査（NHIS）によると、米国では成人の約25.7％、子供の18.9％が季節性アレルギー、湿疹、食物アレルギーと診断されたと報告しています。このデータは、合併症を減らし、生活の質を向上させるために、より良い診断ツールと早期発見戦略が緊急に必要であることを反映しており、アレルギー疾患の有病率が増加していることを強調しています。

さらに、Allergy &Asthma Networkの統計によれば、毎年5,000万人以上の米国人がアレルギーに悩まされており、米国における慢性疾患の原因の第6位となっています。食物アレルギーだけでも、推定560万人の子供（約13人に1人）、約2,600万人の成人が罹患しており、正確で利用しやすい診断ソリューションの必要性をさらに強調しています。さらに、アレルゲンが引き金となることが多い喘息は、420万人の子供を含む2,500万人以上の米国人が罹患しています。これらの数字は、アレルギー疾患によるヘルスケアへの負担が増大していることを示しており、高度な診断と早期介入への投資の必要性を裏付けています。

米国の人口統計学的変化

• 成人：
  • 非ヒスパニック系白人の成人は、非ヒスパニック系黒人（24％）、ヒスパニック系（18.8％）、非ヒスパニック系アジア人（17％）と比較して、季節性アレルギー（28.4％）を有する可能性が高くなりました。
  • 湿疹の有病率は、男性（5.7％）よりも女性（8.9％）で高くなりました。
  • 非ヒスパニック系黒人の成人の食物アレルギー有病率は8.5％と、ヒスパニック系（4.4％）、非ヒスパニック系白人（6.2％）、非ヒスパニック系アジア人（4.5％）の成人より高くなりました。
• 子供：
  • 男児（20％）は女児（17.7％）よりも季節性アレルギーを有する可能性が高くなりました。
  • 湿疹の有病率は6～11歳が最も高く（12.1％）、次いで0～5歳（10.4％）、12～17歳（9.8％）でした。
  • 非ヒスパニック系黒人の子供たちは、ヒスパニック系（5％）、非ヒスパニック系白人（5.3％）の子供たちに比べ、食物アレルギーを持つ可能性が高くなりました（7.6％）。

アレルギー疾患の経済的影響も大きく、救急受診、入院、生産性の低下により、米国のヘルスケアシステムに毎年数十億米ドルの損失を与えています。有病率の上昇、ヘルスケアコスト、重篤なアレルギー反応のリスクが重なり、プライマリケアから専門クリニック、さらには家庭用検査キットまで、さまざまな場面で正確性、迅速性、アクセシビリティを提供できる革新的なアレルギー診断に対する切実な市場需要が生まれています。

世界のアレルギー診断市場における主要企業には、Thermo Fisher Scientific, Inc.、HYCOR Biomedical、EUROIMMUN Medizinische Labordiagnostika AG（PerkinElmer, Inc.）、Omega Diagnostics Group PLC、Lincoln Diagnostics, Inc.、AESKU.GROUP GmbH、Minaris Medical America, Inc.、HOB Biotech Group Corp.、DASIT Group SPA、R-Biopharm AG、bioMerieux、Siemens Healthcare GmbHなどがあります。

これらの企業は、世界市場でのプレゼンスを強化し、アレルギー検査ポートフォリオを拡大するために、新製品の発売、規制当局の承認、技術の進歩などの戦略的イニシアティブに積極的に取り組んでいます。例えば、2022年5月、Thermo Fisher Scientificは、ハイスループットin vitroアレルギー・自己免疫検査用のPhadia 2500+シリーズを発売し、米国におけるアレルギー診断の提供を拡大し、ラボの効率と精密診断を強化しました。この発売は、包括的なアレルギーパネルと分子レベルの検査に対する需要の高まりをサポートするもので、米国や欧州などの主要市場において、特に高齢者・小児における食物アレルギーと呼吸器アレルギーの症例の増加に対応するものです。

アレルギー診断市場レポートのハイライト

• 製品・サービス別では、消耗品が2024年に63.14%と最大の売上シェアを占めました。この優位性は、アレルギー検査手順に不可欠な試薬、検査キット、その他の消耗品の補充が頻繁に必要になること、および世界的にアレルギー診断検査数が増加していることに起因しています。
• アレルゲン別では、吸入が市場を独占し、2024年には49.72%の最大収益シェアを占めました。これは主に、花粉、ダニ、カビの胞子、動物のフケなどの空気中のアレルゲンによって引き起こされる呼吸器アレルギーの有病率が高いためであり、広範でルーチンの診断検査が必要です。
• 検査タイプ別では、試験管内検査が2024年に最も高い収益シェアで市場をリードしました。試験管内検査が好まれるのは、その安全性、再現性、複数のアレルゲンを同時に検出できる包括的なパネルを提供する能力によるもので、臨床・研究の両方の場面で好まれています。
• 最終用途別では、病院と診療所が2024年に37.23%の最高売上シェアを占めました。これは、病院の外来診療へのアレルギー診断の統合が進んでいること、専門的なアレルギー診療への紹介が増加していること、臨床現場において正確な検査室ベースの検査が求められていることによるものです。
• 地域別では、北米が世界市場をリードし、2024年の売上高の36.53%を占めました。この優位性は、同地域の確立されたヘルスケアインフラ、アレルギー関連の健康リスクに対する高い認識、強力な償還政策、高度な診断ソリューションを提供する主要な業界プレイヤーの存在に起因します。
• アジア太平洋地域は、2024～2030年までのCAGRが11.43%で、最も速い成長が予測されています。この成長を促進する要因としては、都市化の進展、環境汚染の増加、新たな食物アレルギーにつながる食生活の変化、特に中国やインドなどの新興経済国における医療サービスへのアクセスの拡大などが挙げられます。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 アレルギー診断市場の変数、動向、範囲

• 市場系統展望
  • 親市場展望
  • 関連/補助的な市場展望
• 市場力学
  • 市場促進要因分析
  • 市場抑制要因分析
• アレルギー診断市場分析ツール
  • 業界分析- ポーターのファイブフォース分析
  • PESTEL分析

第4章 アレルギー診断市場：製品・サービスの推定・動向分析

• 製品・サービス別の市場シェア、2024年および2030年
• セグメントダッシュボード
• 製品・サービス別の世界のアレルギー診断市場の展望
• 2018～2030年までの市場規模と予測および動向分析
  • 機器
  • 消耗品
  • サービス

第5章 アレルギー診断市場：アレルゲンの推定・動向分析

• アレルゲン別の市場シェア、2024年および2030年
• セグメントダッシュボード
• アレルゲン別の世界のアレルギー診断市場
• 2018～2030年までの市場規模と予測および動向分析
  • 食品
  • 吸入
  • その他

第6章 アレルギー診断市場：検査タイプの推定・動向分析

• 検査タイプ別の市場シェア、2024年および2030年
• セグメントダッシュボード
• 検査タイプ別の世界のアレルギー診断市場の展望
• 2018～2030年までの市場規模と予測および動向分析
  • in vivo試験

第7章 アレルギー診断市場：最終用途の推定・動向分析

• 最終用途別の市場シェア、2024年および2030年
• セグメントダッシュボード
• 最終用途別の世界のアレルギー診断市場展望
• 2018～2030年までの市場規模と予測および動向分析
  • 研究機関
  • 病院・診療所
  • 診断検査室
  • その他

第8章 アレルギー診断市場：地域の推定・動向分析

• 地域別の市場シェア分析、2024年および2030年
• 地域市場ダッシュボード
• 世界の地域市場のスナップショット
• 市場規模、予測、動向分析、2018～2030年
• 北米
  • 北米：SWOT分析
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • 欧州：SWOT分析
  • 英国
  • ドイツ
  • フランス
  • イタリア
  • スペイン
  • ノルウェー
  • スウェーデン
  • デンマーク
• アジア太平洋
  • アジア太平洋地域：SWOT分析
  • 日本
  • 中国
  • インド
  • オーストラリア
  • 韓国
  • タイ
• ラテンアメリカ
  • ラテンアメリカ：SWOT分析
  • ブラジル
  • アルゼンチン
• 中東・アフリカ
  • MEA：SWOT分析
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • クウェート

第9章 競合情勢

• 主要市場参入企業による最近の動向と影響分析
• 企業/競合の分類
• ベンダー情勢
  • 主要販売代理店およびチャネルパートナーのリスト
  • Key customers
  • Key company market share analysis, 2024
  • Thermo Fisher Scientific, Inc.
  • HYCOR Biomedical
  • EUROIMMUN Medizinische Labordiagnostika AG（PerkinElmer, Inc.）
  • Omega Diagnostics Group PLC
  • Lincoln Diagnostics, Inc.
  • AESKU.GROUP GmbH
  • Minaris Medical America, Inc.
  • HOB Biotech Group Corp., Ltd.
  • DASIT Group SPA
  • R-Biopharm AG
  • bioMerieux
  • Siemens Healthcare GmbH

List of Tables

• Table 1 List of Abbreviation
• Table 2 List of Secondary Sources
• Table 3 Regulatory Framework
• Table 4 Global Allergy Diagnostics Market, By Region, 2018 - 2030 (USD Million)
• Table 5 Global Allergy Diagnostics Market, By Products and Services, 2018 - 2030 (USD Million)
• Table 6 Global Allergy Diagnostics Market, By Allergen, 2018 - 2030 (USD Million)
• Table 7 Global Allergy Diagnostics Market, By Test Type, 2018 - 2030 (USD Million)
• Table 8 Global Allergy Diagnostics Market, By End use, 2018 - 2030 (USD Million)
• Table 9 North America Allergy Diagnostics Market, By Country, 2018 - 2030 (USD Million)
• Table 10 North America Allergy Diagnostics Market, By Products and Services, 2018 - 2030 (USD Million)
• Table 11 North America Allergy Diagnostics Market, By Allergen, 2018 - 2030 (USD Million)
• Table 12 North America Allergy Diagnostics Market, By Test Type, 2018 - 2030 (USD Million)
• Table 13 North America Allergy Diagnostics Market, By End use, 2018 - 2030 (USD Million)
• Table 14 North America Allergy Diagnostics Market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 15 U.S. Allergy Diagnostics Market, By Products and Services, 2018 - 2030 (USD Million)
• Table 16 U.S. Allergy Diagnostics Market, By Allergen, 2018 - 2030 (USD Million)
• Table 17 U.S Allergy Diagnostics Market, By Test Type, 2018 - 2030 (USD Million)
• Table 18 U.S. Allergy Diagnostics Market, By End use, 2018 - 2030 (USD Million)
• Table 19 Canada Allergy Diagnostics Market, By Products and Services, 2018 - 2030 (USD Million)
• Table 20 Canada Allergy Diagnostics Market, By Allergen, 2018 - 2030 (USD Million)
• Table 21 Global Allergy Diagnostics Market, By Test Type, 2018 - 2030 (USD Million)
• Table 22 Canada Allergy Diagnostics Market, By End use, 2018 - 2030 (USD Million)
• Table 23 Mexico Allergy Diagnostics Market, By Products and Services, 2018 - 2030 (USD Million)
• Table 24 Mexico Allergy Diagnostics Market, By Allergen, 2018 - 2030 (USD Million)
• Table 25 Mexico Allergy Diagnostics Market, By Test Type, 2018 - 2030 (USD Million)
• Table 26 Mexico Allergy Diagnostics Market, By End use, 2018 - 2030 (USD Million)
• Table 27 Europe Allergy Diagnostics Market, By Country, 2018 - 2030 (USD Million)
• Table 28 Europe Allergy Diagnostics Market, By Products and Services, 2018 - 2030 (USD Million)
• Table 29 Europe Allergy Diagnostics Market, By Allergen, 2018 - 2030 (USD Million)
• Table 30 Europe Allergy Diagnostics Market, By Test Type, 2018 - 2030 (USD Million)
• Table 31 Europe Allergy Diagnostics Market, By End use, 2018 - 2030 (USD Million)
• Table 32 UK Allergy Diagnostics Market, By Products and Services, 2018 - 2030 (USD Million)
• Table 33 UK Allergy Diagnostics Market, By Allergen, 2018 - 2030 (USD Million)
• Table 34 UK Allergy Diagnostics Market, By Test Type, 2018 - 2030 (USD Million)
• Table 35 UK Allergy Diagnostics Market, By End use, 2018 - 2030 (USD Million)
• Table 36 Germany Allergy Diagnostics Market, By Products and Services, 2018 - 2030 (USD Million)
• Table 37 Germany Allergy Diagnostics Market, By Allergen, 2018 - 2030 (USD Million)
• Table 38 Germany Allergy Diagnostics Market, By Test Type, 2018 - 2030 (USD Million)
• Table 39 Germany America Allergy Diagnostics Market, By End use, 2018 - 2030 (USD Million)
• Table 40 France Allergy Diagnostics Market, By Products and Services, 2018 - 2030 (USD Million)
• Table 41 France Allergy Diagnostics Market, By Allergen, 2018 - 2030 (USD Million)
• Table 42 France Rapid Allergy Diagnostics Market, By Test Type, 2018 - 2030 (USD Million)
• Table 43 France Allergy Diagnostics Market, By End use, 2018 - 2030 (USD Million)
• Table 44 Spain Allergy Diagnostics Market, By Products and Services, 2018 - 2030 (USD Million)
• Table 45 Spain Allergy Diagnostics Market, By Allergen, 2018 - 2030 (USD Million)
• Table 46 Spain Allergy Diagnostics Market, By Test Type, 2018 - 2030 (USD Million)
• Table 47 Spain Allergy Diagnostics Market, By End use, 2018 - 2030 (USD Million)
• Table 48 Italy Allergy Diagnostics Market, By Products and Services, 2018 - 2030 (USD Million)
• Table 49 Italy Allergy Diagnostics Market, By Allergen, 2018 - 2030 (USD Million)
• Table 50 Italy Allergy Diagnostics Market, By Test Type, 2018 - 2030 (USD Million)
• Table 51 Italy Allergy Diagnostics Market, By End use, 2018 - 2030 (USD Million)
• Table 52 Asia Pacific Allergy Diagnostics Market, By Country, 2018 - 2030 (USD Million)
• Table 53 Asia Pacific Allergy Diagnostics Market, By Products and Services, 2018 - 2030 (USD Million)
• Table 54 Asia Pacific Allergy Diagnostics Market, By Allergen, 2018 - 2030 (USD Million)
• Table 55 Asia Pacific Allergy Diagnostics Market, By Test Type, 2018 - 2030 (USD Million)
• Table 56 Asia-Pacific Allergy Diagnostics Market, By End use, 2018 - 2030 (USD Million)
• Table 57 China Allergy Diagnostics Market, By Products and Services, 2018 - 2030 (USD Million)
• Table 58 China Allergy Diagnostics Market, By Allergen, 2018 - 2030 (USD Million)
• Table 59 China Allergy Diagnostics Market, By Test Type, 2018 - 2030 (USD Million)
• Table 60 China Allergy Diagnostics Market, By End use, 2018 - 2030 (USD Million)
• Table 61 Japan Allergy Diagnostics Market, By Products and Services, 2018 - 2030 (USD Million)
• Table 62 Japan Allergy Diagnostics Market, By Allergen, 2018 - 2030 (USD Million)
• Table 63 Japan Allergy Diagnostics Market, By Test Type, 2018 - 2030 (USD Million)
• Table 64 Japan Allergy Diagnostics Market, By End use, 2018 - 2030 (USD Million)
• Table 65 India Allergy Diagnostics Market, By Products and Services, 2018 - 2030 (USD Million)
• Table 66 India Allergy Diagnostics Market, By Allergen, 2018 - 2030 (USD Million)
• Table 67 India Allergy Diagnostics Market, By Test Type, 2018 - 2030 (USD Million)
• Table 68 India Allergy Diagnostics Market, By End use, 2018 - 2030 (USD Million)
• Table 69 South Korea Allergy Diagnostics Market, By Products and Services, 2018 - 2030 (USD Million)
• Table 70 South Korea Allergy Diagnostics Market, By Allergen, 2018 - 2030 (USD Million)
• Table 71 South Korea Allergy Diagnostics Market, By Test Type, 2018 - 2030 (USD Million)
• Table 72 South Korea Allergy Diagnostics Market, By End use, 2018 - 2030 (USD Million)
• Table 73 Australia Allergy Diagnostics Market, By Products and Services, 2018 - 2030 (USD Million)
• Table 74 Australia Allergy Diagnostics Market, By Allergen, 2018 - 2030 (USD Million)
• Table 75 Australia Allergy Diagnostics Market, By Test Type, 2018 - 2030 (USD Million)
• Table 76 Australia Allergy Diagnostics Market, By End use, 2018 - 2030 (USD Million)
• Table 77 Latin America Allergy Diagnostics Market, By Country, 2018 - 2030 (USD Million)
• Table 78 Latin America Allergy Diagnostics Market, By Products and Services, 2018 - 2030 (USD Million)
• Table 79 Latin America Allergy Diagnostics Market, By Allergen, 2018 - 2030 (USD Million)
• Table 80 Latin America Allergy Diagnostics Market, By Test Type, 2018 - 2030 (USD Million)
• Table 81 Latin America Allergy Diagnostics Market, By End use, 2018 - 2030 (USD Million)
• Table 82 Brazil Allergy Diagnostics Market, By Products and Services, 2018 - 2030 (USD Million)
• Table 83 Brazil Allergy Diagnostics Market, By Allergen, 2018 - 2030 (USD Million)
• Table 84 Brazil Allergy Diagnostics Market, By Test Type, 2018 - 2030 (USD Million)
• Table 85 Brazil Allergy Diagnostics Market, By End use, 2018 - 2030 (USD Million)
• Table 86 Argentina Allergy Diagnostics Market, By Products and Services, 2018 - 2030 (USD Million)
• Table 87 Argentina Allergy Diagnostics Market, By Allergen, 2018 - 2030 (USD Million)
• Table 88 Argentina Allergy Diagnostics Market, By Test Type, 2018 - 2030 (USD Million)
• Table 89 Argentina Allergy Diagnostics Market, By End use, 2018 - 2030 (USD Million)
• Table 90 MEA Allergy Diagnostics Market, By Country, 2018 - 2030 (USD Million)
• Table 91 MEA Allergy Diagnostics Market, By Products and Services, 2018 - 2030 (USD Million)
• Table 92 MEA Allergy Diagnostics Market, By Allergen, 2018 - 2030 (USD Million)
• Table 93 Global Allergy Diagnostics Market, By Test Type, 2018 - 2030 (USD Million)
• Table 94 MEA Allergy Diagnostics Market, By End use, 2018 - 2030 (USD Million)
• Table 95 South Africa Allergy Diagnostics Market, By Products and Services, 2018 - 2030 (USD Million)
• Table 96 South Africa Allergy Diagnostics Market, By Allergen, 2018 - 2030 (USD Million)
• Table 97 South Africa Allergy Diagnostics Market, By Test Type, 2018 - 2030 (USD Million)
• Table 98 South Africa Allergy Diagnostics Market, By End use, 2018 - 2030 (USD Million)
• Table 99 UAE Allergy Diagnostics Market, By Products and Services, 2018 - 2030 (USD Million)
• Table 100 UAE Allergy Diagnostics Market, By Allergen, 2018 - 2030 (USD Million)
• Table 101 UAE Allergy Diagnostics Market, By Test Type, 2018 - 2030 (USD Million)
• Table 102 UAE Allergy Diagnostics Market, By End use, 2018 - 2030 (USD Million)
• Table 103 Saudi Arabia Allergy Diagnostics Market, By Products and Services, 2018 - 2030 (USD Million)
• Table 104 Saudi Arabia Allergy Diagnostics Market, By Allergen, 2018 - 2030 (USD Million)
• Table 105 Saudi Arabia Allergy Diagnostics Market, By Test Type, 2018 - 2030 (USD Million)
• Table 106 Saudi Arabia Allergy Diagnostics Market, By End use, 2018 - 2030 (USD Million)
• Table 107 Kuwait Allergy Diagnostics Market, By Products and Services, 2018 - 2030 (USD Million)
• Table 108 Kuwait Allergy Diagnostics Market, By Allergen, 2018 - 2030 (USD Million)
• Table 109 Kuwait Allergy Diagnostics Market, By Test Type, 2018 - 2030 (USD Million)
• Table 110 Kuwait Allergy Diagnostics Market, By End use, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 Market research process
• Fig. 2 Data triangulation techniques
• Fig. 3 Primary research pattern
• Fig. 4 Primary interviews in North America
• Fig. 5 Primary interviews in Europe
• Fig. 6 Primary interviews in APAC
• Fig. 7 Primary interviews in Latin America
• Fig. 8 Primary interviews in MEA
• Fig. 9 Market research approaches
• Fig. 10 Value-chain-based sizing & forecasting
• Fig. 11 QFD modeling for market share assessment
• Fig. 12 Market formulation & validation
• Fig. 13 Allergy Diagnostics: market outlook
• Fig. 14 Allergy Diagnostics competitive insights
• Fig. 15 Parent market outlook
• Fig. 16 Related/ancillary market outlook.
• Fig. 17 Penetration and growth prospect mapping
• Fig. 18 Industry value chain analysis
• Fig. 19 Allergy Diagnostics driver impact
• Fig. 20 Allergy Diagnostics restraint impact
• Fig. 21 Allergy Diagnostics strategic initiatives analysis
• Fig. 22 Allergy Diagnostics: Products and Services movement analysis
• Fig. 23 Allergy Diagnostics: Products and Services outlook and key takeaways
• Fig. 24 Instruments market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 25 Consumables market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 26 Services market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 27 Allergy Diagnostics: Allergen movement analysis
• Fig. 28 Allergy Diagnostics: Allergen outlook and key takeaways
• Fig. 29 Food market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 30 Dairy Products market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 31 Poultry Product market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 32 Tree Nuts market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 33 Peanuts market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 34 Shellfish market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 35 Wheat market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 36 Soys market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 37 Other Food Allergens market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 38 Inhaled market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 39 Other Allergens market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 40 Allergy Diagnostics: Test Type movement analysis
• Fig. 41 Allergy Diagnostics: Test Type outlook and key takeaways
• Fig. 42 In Vivo Test market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 43 Skin Prick Test market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 44 Intradermal Test market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 45 Patch Test market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 46 Others market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 47 In Vitro market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 48 Allergy Diagnostics: End use movement analysis
• Fig. 49 Allergy Diagnostics: End use outlook and key takeaways
• Fig. 50 Hospitals & Clinics market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 51 Diagnostics Laboratories market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 52 Research Institutions market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 53 Others market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 54 Global allergy diagnostics market: Regional movement analysis
• Fig. 55 Global allergy diagnostics market: Regional outlook and key takeaways
• Fig. 56 Global allergy diagnostics market shares and leading players
• Fig. 57 North America
• Fig. 58 North America market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 59 U.S.
• Fig. 60 U.S. market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 61 Canada
• Fig. 62 Canada market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 63 Mexico
• Fig. 64 Mexico market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 65 Europe
• Fig. 66 Europe market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 67 UK
• Fig. 68 UK market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 69 Germany
• Fig. 70 Germany market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 71 France
• Fig. 72 France market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 73 Italy
• Fig. 74 Italy market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 75 Spain
• Fig. 76 Spain market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 77 Denmark
• Fig. 78 Denmark market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 79 Sweden
• Fig. 80 Sweden market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 81 Norway
• Fig. 82 Norway market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 83 Asia Pacific
• Fig. 84 Asia Pacific market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 85 China
• Fig. 86 China market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 87 Japan
• Fig. 88 Japan market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 89 India
• Fig. 90 India market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 91 Thailand
• Fig. 92 Thailand market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 93 South Korea
• Fig. 94 South Korea market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 95 Australia
• Fig. 96 Australia market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 97 Latin America
• Fig. 98 Latin America market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 99 Brazil
• Fig. 100 Brazil market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 101 Argentina
• Fig. 102 Argentina market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 103 Middle East and Africa
• Fig. 104 Middle East and Africa market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 105 South Africa
• Fig. 106 South Africa market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 107 Saudi Arabia
• Fig. 108 Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 109 UAE
• Fig. 110 UAE market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 111 Kuwait
• Fig. 112 Kuwait market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 113 Market share of key market players - Allergy Diagnostics

Allergy Diagnostics Market Growth & Trends:

The global allergy diagnostics market size is expected to reach USD 11.63 billion by 2030, registering a CAGR of 10.39% from 2025 to 2030, according to a new report by Grand View Research, Inc. Allergies continue to be a significant public health concern in the U.S. and worldwide, affecting both children and adults across all demographics. According to the CDC's 2023 National Health Interview Survey (NHIS), approximately 25.7% of adults and 18.9% of children in the U.S. reported being diagnosed with seasonal allergies, eczema, or food allergies. This data highlights the growing prevalence of allergic conditions, reflecting an urgent need for better diagnostic tools and early detection strategies to reduce complications and improve quality of life.

Additionally, statistics from the Allergy & Asthma Network reveal that over 50 million Americans suffer from allergies each year, making them the sixth leading cause of chronic illness in the U.S. Food allergies alone affect an estimated 5.6 million children (around one in 13), and about 26 million adults further underlining the need for precise and accessible diagnostic solutions. Moreover, asthma, which is often triggered by allergens, affects more than 25 million Americans, including 4.2 million children. These figures point to the growing healthcare burden of allergic diseases and support the case for investments in advanced diagnostics and early intervention.

U.S. Demographic Variations:

• Adults:
  • Non-Hispanic White adults were more likely to have seasonal allergies (28.4%) compared to Non-Hispanic Black (24%), Hispanic (18.8%), and Non-Hispanic Asian (17%) adults.
  • Eczema prevalence was higher among women (8.9%) than men (5.7%).
  • Non-Hispanic Black adults had a higher prevalence of food allergies (8.5%) compared to Hispanic (4.4%), Non-Hispanic White (6.2%), and Non-Hispanic Asian (4.5%) adults.
• Children:
  • Boys (20%) were more likely to have seasonal allergies than girls (17.7%).
  • Children aged 6-11 years had the highest prevalence of eczema (12.1%), followed by those aged 0-5 years (10.4%), and 12-17 years (9.8%).
  • Non-Hispanic Black children were more likely to have food allergies (7.6%) compared to Hispanic (5%) and Non-Hispanic White (5.3%) children

The economic impact of allergic diseases is also substantial, costing the U.S. healthcare system billions annually due to emergency visits, hospitalizations, and lost productivity. The combination of rising prevalence, healthcare costs, and the risk of severe allergic reactions has created a compelling market demand for innovative allergy diagnostics that can offer accuracy, speed, and accessibility across various settings, from primary care to specialty clinics and even at-home testing kits.

Some of the key players in the global allergy diagnostics market include Thermo Fisher Scientific, Inc., HYCOR Biomedical, EUROIMMUN Medizinische Labordiagnostika AG (PerkinElmer, Inc.), Omega Diagnostics Group PLC, Lincoln Diagnostics, Inc., AESKU.GROUP GmbH, Minaris Medical America, Inc., HOB Biotech Group Corp., Ltd., DASIT Group SPA, R-Biopharm AG, bioMerieux, and Siemens Healthcare GmbH.

These companies are actively engaged in strategic initiatives such as new product launches, regulatory approvals, and technology advancements to strengthen their global market presence and expand their allergy testing portfolios. For instance, in May 2022, Thermo Fisher Scientific expanded its allergy diagnostics offering in the U.S. by launching its Phadia 2500+ series for high-throughput in vitro allergy and autoimmune testing, enhancing lab efficiency and precision diagnostics. This launch supports the growing demand for comprehensive allergy panels and molecular-level testing, addressing increasing cases of food and respiratory allergies, particularly in aging and pediatric populations across key markets like the U.S. and Europe.

Allergy Diagnostics Market Report Highlights:

• Based on products and services, consumables accounted for the largest revenue share of 63.14% in 2024. This dominance is attributed to the frequent need for replenishment of reagents, test kits, and other consumable materials essential for allergy testing procedures, as well as the increasing volume of allergy diagnostic tests conducted globally.
• Based on allergen, inhaled dominated the market and accounted for the largest revenue share of 49.72% in 2024. This is primarily due to the high prevalence of respiratory allergies caused by airborne allergens such as pollen, dust mites, mold spores, and animal dander, which necessitate widespread and routine diagnostic testing.
• Based on test type, the in vitro test led the market with the highest revenue share in 2024. The preference for in vitro tests is driven by their safety, reproducibility, and ability to provide comprehensive panels that can detect multiple allergens simultaneously, making them a preferred choice in both clinical and research settings.
• Based on end use, hospitals and clinics held the highest revenue share of 37.23% in 2024. This is due to the growing integration of allergy diagnostics into hospital outpatient services, increasing referrals for specialized allergy care, and the demand for accurate, laboratory-based testing within clinical settings.
• Based on region, North America led the global market, accounting for 36.53% of the revenue in 2024. This dominance is attributed to the region's well-established healthcare infrastructure, high awareness of allergy-related health risks, strong reimbursement policies, and the presence of key industry players offering advanced diagnostic solutions.
• The Asia Pacific region is projected to witness the fastest growth, with a CAGR of 11.43% from 2024 to 2030. Factors driving this growth include rising urbanization, increasing environmental pollution, changing dietary habits leading to new food allergies, and expanding access to healthcare services, particularly in emerging economies such as China and India.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Products and Services
  • 1.2.2. Allergen
  • 1.2.3. Test Type
  • 1.2.4. End Use
  • 1.2.5. Regional scope
  • 1.2.6. Estimates and forecasts timeline.
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
  • 1.4.5. Details of primary research
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
  • 1.7.2. Approach 1: Commodity flow approach
  • 1.7.3. Volume price analysis (Model 2)
  • 1.7.4. Approach 2: Volume price analysis
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Products and Services Outlook
  • 2.2.2. Test Type Outlook
  • 2.2.3. Allergen Outlook
  • 2.2.4. End Use Outlook
  • 2.2.5. Regional outlook
• 2.3. Competitive Insights

Chapter 3. Allergy Diagnostics Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook.
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. Increasing Allergy Prevalence
    • 3.2.1.2. Advancements in Diagnostic Techniques
    • 3.2.1.3. Significant investments from government bodies
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. Limited accessibility to advanced technologies
    • 3.2.2.2. High Manufacturing Costs
• 3.3. Allergy Diagnostics Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
  • 3.3.2. PESTEL Analysis

Chapter 4. Allergy Diagnostics Market: Products and Services Estimates & Trend Analysis

• 4.1. Products and Services Market Share, 2024 & 2030
• 4.2. Segment Dashboard
• 4.3. Global Allergy Diagnostics Market by Products and Services Outlook
• 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 4.4.1. Instruments
    • 4.4.1.1. Instruments market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.4.2. Consumables
    • 4.4.2.1. Consumables market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.4.3. Services
    • 4.4.3.1. Services market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Allergy Diagnostics Market: Allergen Estimates & Trend Analysis

• 5.1. Allergen Market Share, 2024 & 2030
• 5.2. Segment Dashboard
• 5.3. Global Allergy Diagnostics Market by Allergen Outlook
• 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 5.4.1. Food
    • 5.4.1.1. Food market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.1.2. Dairy Products
      • 5.4.1.2.1. Dairy products market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.1.3. Poultry Product
      • 5.4.1.3.1. Poultry products market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.1.4. Tree Nuts
      • 5.4.1.4.1. Tree nuts market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.1.5. Peanuts
      • 5.4.1.5.1. Peanuts market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.1.6. Shellfish
      • 5.4.1.6.1. Shellfish market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.1.7. Wheat
      • 5.4.1.7.1. Wheat market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.1.8. Soys
      • 5.4.1.8.1. Soys market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.1.9. Other Food Allergens
      • 5.4.1.9.1. Other food allergens market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.4.2. Inhaled
    • 5.4.2.1. Inhaled market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.4.3. Other Allergens
    • 5.4.3.1. Other Allergens market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Allergy Diagnostics Market: Test Type Estimates & Trend Analysis

• 6.1. Test Type Market Share, 2024 & 2030
• 6.2. Segment Dashboard
• 6.3. Global Allergy Diagnostics Market by Test Type Outlook
• 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 6.4.1. In Vivo Test
    • 6.4.1.1. In Vivo Test market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.1.2. Skin Prick Test
      • 6.4.1.2.1. Skin Prick Test market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.1.3. Intradermal Test
      • 6.4.1.3.1. Intradermal Test market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.1.4. Patch Test
      • 6.4.1.4.1. Patch Test market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.1.5. In vitro Test
    • 6.4.1.6. In Vitro market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Allergy Diagnostics Market: End Use Estimates & Trend Analysis

• 7.1. End Use Market Share, 2024 & 2030
• 7.2. Segment Dashboard
• 7.3. Global Allergy Diagnostics Market by End Use Outlook
• 7.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 7.4.1. Research Institutions
    • 7.4.1.1. Research Institutions market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4.2. Hospitals & Clinics
    • 7.4.2.1. Hospitals & Clinics market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4.3. Diagnostic Laboratories
    • 7.4.3.1. Diagnostic Laboratories market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4.4. Others
    • 7.4.4.1. Others market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Allergy Diagnostics Market: Regional Estimates & Trend Analysis

• 8.1. Regional Market Share Analysis, 2024 & 2030
• 8.2. Regional Market Dashboard
• 8.3. Global Regional Market Snapshot
• 8.4. Market Size, & Forecasts, Trend Analysis, 2018 to 2030:
• 8.5. North America
  • 8.5.1. North America: SWOT Analysis
  • 8.5.2. U.S.
    • 8.5.2.1. Key country dynamics
    • 8.5.2.2. Regulatory framework
    • 8.5.2.3. Competitive scenario
    • 8.5.2.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.5.3. Canada
    • 8.5.3.1. Key country dynamics
    • 8.5.3.2. Regulatory framework
    • 8.5.3.3. Competitive scenario
    • 8.5.3.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.5.4. Mexico
    • 8.5.4.1. Key country dynamics
    • 8.5.4.2. Regulatory framework
    • 8.5.4.3. Competitive scenario
    • 8.5.4.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
• 8.6. Europe
  • 8.6.1. Europe: SWOT Analysis
  • 8.6.2. UK
    • 8.6.2.1. Key country dynamics
    • 8.6.2.2. Regulatory framework
    • 8.6.2.3. Competitive scenario
    • 8.6.2.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6.3. Germany
    • 8.6.3.1. Key country dynamics
    • 8.6.3.2. Regulatory framework
    • 8.6.3.3. Competitive scenario
    • 8.6.3.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6.4. France
    • 8.6.4.1. Key country dynamics
    • 8.6.4.2. Regulatory framework
    • 8.6.4.3. Competitive scenario
    • 8.6.4.4. France market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6.5. Italy
    • 8.6.5.1. Key country dynamics
    • 8.6.5.2. Regulatory framework
    • 8.6.5.3. Competitive scenario
    • 8.6.5.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6.6. Spain
    • 8.6.6.1. Key country dynamics
    • 8.6.6.2. Regulatory framework
    • 8.6.6.3. Competitive scenario
    • 8.6.6.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6.7. Norway
    • 8.6.7.1. Key country dynamics
    • 8.6.7.2. Regulatory framework
    • 8.6.7.3. Competitive scenario
    • 8.6.7.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6.8. Sweden
    • 8.6.8.1. Key country dynamics
    • 8.6.8.2. Regulatory framework
    • 8.6.8.3. Competitive scenario
    • 8.6.8.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6.9. Denmark
    • 8.6.9.1. Key country dynamics
    • 8.6.9.2. Regulatory framework
    • 8.6.9.3. Competitive scenario
    • 8.6.9.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
• 8.7. Asia Pacific
  • 8.7.1. Asia Pacific: SWOT Analysis
  • 8.7.2. Japan
    • 8.7.2.1. Key country dynamics
    • 8.7.2.2. Regulatory framework
    • 8.7.2.3. Competitive scenario
    • 8.7.2.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.7.3. China
    • 8.7.3.1. Key country dynamics
    • 8.7.3.2. Regulatory framework
    • 8.7.3.3. Competitive scenario
    • 8.7.3.4. China market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.7.4. India
    • 8.7.4.1. Key country dynamics
    • 8.7.4.2. Regulatory framework
    • 8.7.4.3. Competitive scenario
    • 8.7.4.4. India market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.7.5. Australia
    • 8.7.5.1. Key country dynamics
    • 8.7.5.2. Regulatory framework
    • 8.7.5.3. Competitive scenario
    • 8.7.5.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.7.6. South Korea
    • 8.7.6.1. Key country dynamics
    • 8.7.6.2. Regulatory framework
    • 8.7.6.3. Competitive scenario
    • 8.7.6.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.7.7. Thailand
    • 8.7.7.1. Key country dynamics
    • 8.7.7.2. Regulatory framework
    • 8.7.7.3. Competitive scenario
    • 8.7.7.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
• 8.8. Latin America
  • 8.8.1. Latin America: SWOT Analysis
  • 8.8.2. Brazil
    • 8.8.2.1. Key country dynamics
    • 8.8.2.2. Regulatory framework
    • 8.8.2.3. Competitive scenario
    • 8.8.2.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.8.3. Argentina
    • 8.8.3.1. Key country dynamics
    • 8.8.3.2. Regulatory framework
    • 8.8.3.3. Competitive scenario
    • 8.8.3.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
• 8.9. MEA
  • 8.9.1. MEA: SWOT Analysis
  • 8.9.2. South Africa
    • 8.9.2.1. Key country dynamics
    • 8.9.2.2. Regulatory framework
    • 8.9.2.3. Competitive scenario
    • 8.9.2.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.9.3. Saudi Arabia
    • 8.9.3.1. Key country dynamics
    • 8.9.3.2. Regulatory framework
    • 8.9.3.3. Competitive scenario
    • 8.9.3.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.9.4. UAE
    • 8.9.4.1. Key country dynamics
    • 8.9.4.2. Regulatory framework
    • 8.9.4.3. Competitive scenario
    • 8.9.4.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.9.5. Kuwait
    • 8.9.5.1. Key country dynamics
    • 8.9.5.2. Regulatory framework
    • 8.9.5.3. Competitive scenario
    • 8.9.5.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 9. Competitive Landscape

• 9.1. Recent Developments & Impact Analysis, By Key Market Participants
• 9.2. Company/Competition Categorization
• 9.3. Vendor Landscape
  • 9.3.1. List of key distributors and channel partners
  • 9.3.2. Key customers
  • 9.3.3. Key company market share analysis, 2024
  • 9.3.4. Thermo Fisher Scientific, Inc.
    • 9.3.4.1. Company overview
    • 9.3.4.2. Financial performance
    • 9.3.4.3. Services benchmarking
    • 9.3.4.4. Strategic initiatives
  • 9.3.5. HYCOR Biomedical
    • 9.3.5.1. Company overview
    • 9.3.5.2. Financial performance
    • 9.3.5.3. Services benchmarking
    • 9.3.5.4. Strategic initiatives
  • 9.3.6. EUROIMMUN Medizinische Labordiagnostika AG (PerkinElmer, Inc.)
    • 9.3.6.1. Company overview
    • 9.3.6.2. Financial performance
    • 9.3.6.3. Services benchmarking
    • 9.3.6.4. Strategic initiatives
  • 9.3.7. Omega Diagnostics Group PLC
    • 9.3.7.1. Company overview
    • 9.3.7.2. Financial performance
    • 9.3.7.3. Services benchmarking
    • 9.3.7.4. Strategic initiatives
  • 9.3.8. Lincoln Diagnostics, Inc.
    • 9.3.8.1. Company overview
    • 9.3.8.2. Financial performance
    • 9.3.8.3. Services benchmarking
    • 9.3.8.4. Strategic initiatives
  • 9.3.9. AESKU.GROUP GmbH
    • 9.3.9.1. Company overview
    • 9.3.9.2. Financial performance
    • 9.3.9.3. Services benchmarking
    • 9.3.9.4. Strategic initiatives
  • 9.3.10. Minaris Medical America, Inc.
    • 9.3.10.1. Company overview
    • 9.3.10.2. Financial performance
    • 9.3.10.3. Services benchmarking
    • 9.3.10.4. Strategic initiatives
  • 9.3.11. HOB Biotech Group Corp., Ltd.
    • 9.3.11.1. Company overview
    • 9.3.11.2. Financial performance
    • 9.3.11.3. Services benchmarking
    • 9.3.11.4. Strategic initiatives
  • 9.3.12. DASIT Group SPA
    • 9.3.12.1. Company overview
    • 9.3.12.2. Financial performance
    • 9.3.12.3. Services benchmarking
    • 9.3.12.4. Strategic initiatives
  • 9.3.13. R-Biopharm AG
    • 9.3.13.1. Company overview
    • 9.3.13.2. Financial performance
    • 9.3.13.3. Services benchmarking
    • 9.3.13.4. Strategic initiatives
  • 9.3.14. bioMerieux
    • 9.3.14.1. Company overview
    • 9.3.14.2. Financial performance
    • 9.3.14.3. Services benchmarking
    • 9.3.14.4. Strategic initiatives
  • 9.3.15. Siemens Healthcare GmbH
    • 9.3.15.1. Company overview
    • 9.3.15.2. Financial performance
    • 9.3.15.3. Services benchmarking
    • 9.3.15.4. Strategic initiatives